Report Content
Chapter 1. Methodology
1.1. Methodology
1.1.1. Data collection
1.1.2. Data analysis
1.1.3. Forecast
1.1.4. Data validation
1.1.4.1. Breakdown of primary participants
1.2. Market definition
1.3. Forecast parameters
Chapter 2. Executive Summary
2.1. Protein A resins industry 360° synopsis, 2015 – 2026
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Product trends
2.1.4. Matrix type trends
2.1.5. End-use trends
2.1.6. Regional trends
Chapter 3. Protein A Resins Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2015 – 2026
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing demand for therapeutic antibodies
3.3.1.2. Increase in use of chromatography techniques to determine vitamins and detection of additives in food
3.3.1.3. Drug discovery and other research and development
3.3.2. Industry pitfalls and challenges
3.3.2.1. High cost associated with protein A resins
3.4. Growth potential analysis
3.4.1. By application
3.4.2. By product
3.4.3. By matrix type
3.4.4. By end-use
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.5.3. China
3.6. Porter’s analysis
3.7. Competitive landscape, 2019
3.8. PESTEL analysis
Chapter 4. Protein A Resins Market, By Application
4.1. Key segment trends
4.2. Immunoprecipitation
4.2.1. Market size, by region, 2015 - 2026 (USD Million)
4.3. Antibody Purification
4.3.1. Market size, by region, 2015 - 2026 (USD Million)
Chapter 5. Protein A Resins Market, By Product
5.1. Key segment trends
5.2. Natural protein A
5.2.1. Market size, by region, 2015 - 2026 (USD Million)
5.3. Recombinant protein A
5.3.1. Market size, by region, 2015 - 2026 (USD Million)
Chapter 6. Protein A Resins Market, By Matrix Type
6.1. Key segment trends
6.2. Agarose-based matrix
6.2.1. Market size, by region, 2015 - 2026 (USD Million)
6.3. Glass or Silica gel-based matrix
6.3.1. Market size, by region, 2015 - 2026 (USD Million)
6.4. Organic Polymer-based matrix
6.4.1. Market size, by region, 2015 - 2026 (USD Million)
Chapter 7. Protein A Resins Market, By End-use
7.1. Key segment trends
7.2. Biopharmaceutical Companies
7.2.1. Market size, by region, 2015 - 2026 (USD Million)
7.3. Clinical Research Laboratories
7.3.1. Market size, by region, 2015 - 2026 (USD Million)
7.4. Academic Research Institutes
7.4.1. Market size, by region, 2015 - 2026 (USD Million)
7.5. Contract Research Organizations
7.5.1. Market size, by region, 2015 - 2026 (USD Million)
Chapter 8. Protein A Resins Market, By Region
8.1. Key regional trends
8.2. North America
8.2.1. Market size by country, 2015 – 2026 (USD Million)
8.2.2. Market size by application, 2015 – 2026 (USD Million)
8.2.3. Market size by product, 2015 – 2026 (USD Million)
8.2.4. Market size by matrix type, 2015 – 2026 (USD Million)
8.2.5. Market size by end-use, 2015 – 2026 (USD Million)
8.2.6. U.S.
8.2.6.1. Market size by application, 2015 – 2026 (USD Million)
8.2.6.2. Market size by product, 2015 - 2026 (USD Million)
8.2.6.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.2.6.4. Market size by end-use, 2015 - 2026 (USD Million)
8.2.7. Canada
8.2.7.1. Market size by application, 2015 – 2026 (USD Million)
8.2.7.2. Market size by product, 2015 - 2026 (USD Million)
8.2.7.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.2.7.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3. Europe
8.3.1. Market size by country, 2015 – 2026 (USD Million)
8.3.2. Market size by application, 2015 – 2026 (USD Million)
8.3.3. Market size by product, 2015 – 2026 (USD Million)
8.3.4. Market size by matrix type, 2015 – 2026 (USD Million)
8.3.5. Market size by end-use, 2015 – 2026 (USD Million)
8.3.6. Germany
8.3.6.1. Market size by application, 2015 – 2026 (USD Million)
8.3.6.2. Market size by product, 2015 - 2026 (USD Million)
8.3.6.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.6.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3.7. UK
8.3.7.1. Market size by application, 2015 – 2026 (USD Million)
8.3.7.2. Market size by product, 2015 - 2026 (USD Million)
8.3.7.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.7.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3.8. France
8.3.8.1. Market size by application, 2015 – 2026 (USD Million)
8.3.8.2. Market size by product, 2015 - 2026 (USD Million)
8.3.8.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.8.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3.9. Italy
8.3.9.1. Market size by application, 2015 – 2026 (USD Million)
8.3.9.2. Market size by product, 2015 - 2026 (USD Million)
8.3.9.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.9.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3.10. Spain
8.3.10.1. Market size by application, 2015 – 2026 (USD Million)
8.3.10.2. Market size by product, 2015 - 2026 (USD Million)
8.3.10.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.10.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3.11. Russia
8.3.11.1. Market size by application, 2015 – 2026 (USD Million)
8.3.11.2. Market size by product, 2015 - 2026 (USD Million)
8.3.11.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.11.4. Market size by end-use, 2015 - 2026 (USD Million)
8.3.12. Poland
8.3.12.1. Market size by application, 2015 – 2026 (USD Million)
8.3.12.2. Market size by product, 2015 - 2026 (USD Million)
8.3.12.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.3.12.4. Market size by end-use, 2015 - 2026 (USD Million)
8.4. Asia Pacific
8.4.1. Market size by country, 2015 – 2026 (USD Million)
8.4.2. Market size by application, 2015 – 2026 (USD Million)
8.4.3. Market size by product, 2015 – 2026 (USD Million)
8.4.4. Market size by matrix type, 2015 – 2026 (USD Million)
8.4.5. Market size by end-use, 2015 – 2026 (USD Million)
8.4.6. Japan
8.4.6.1. Market size by application, 2015 – 2026 (USD Million)
8.4.6.2. Market size by product, 2015 - 2026 (USD Million)
8.4.6.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.4.6.4. Market size by end-use, 2015 - 2026 (USD Million)
8.4.7. China
8.4.7.1. Market size by application, 2015 – 2026 (USD Million)
8.4.7.2. Market size by product, 2015 - 2026 (USD Million)
8.4.7.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.4.7.4. Market size by end-use, 2015 - 2026 (USD Million)
8.4.8. India
8.4.8.1. Market size by application, 2015 – 2026 (USD Million)
8.4.8.2. Market size by product, 2015 - 2026 (USD Million)
8.4.8.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.4.8.4. Market size by end-use, 2015 - 2026 (USD Million)
8.4.9. Australia
8.4.9.1. Market size by application, 2015 – 2026 (USD Million)
8.4.9.2. Market size by product, 2015 - 2026 (USD Million)
8.4.9.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.4.9.4. Market size by end-use, 2015 - 2026 (USD Million)
8.5. Latin America
8.5.1. Market size by country, 2015 – 2026 (USD Million)
8.5.2. Market size by application, 2015 – 2026 (USD Million)
8.5.3. Market size by product, 2015 – 2026 (USD Million)
8.5.4. Market size by matrix type, 2015 – 2026 (USD Million)
8.5.5. Market size by end-use, 2015 – 2026 (USD Million)
8.5.6. Brazil
8.5.6.1. Market size by application, 2015 – 2026 (USD Million)
8.5.6.2. Market size by product, 2015 - 2026 (USD Million)
8.5.6.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.5.6.4. Market size by end-use, 2015 - 2026 (USD Million)
8.5.7. Mexico
8.5.7.1. Market size by application, 2015 – 2026 (USD Million)
8.5.7.2. Market size by product, 2015 - 2026 (USD Million)
8.5.7.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.5.7.4. Market size by end-use, 2015 - 2026 (USD Million)
8.5.8. Argentina
8.5.8.1. Market size by application, 2015 – 2026 (USD Million)
8.5.8.2. Market size by product, 2015 - 2026 (USD Million)
8.5.8.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.5.8.4. Market size by end-use, 2015 - 2026 (USD Million)
8.6. Middle East & Africa (MEA)
8.6.1. Market size by country, 2015 – 2026 (USD Million)
8.6.2. Market size by application, 2015 – 2026 (USD Million)
8.6.3. Market size by product, 2015 – 2026 (USD Million)
8.6.4. Market size by matrix type, 2015 – 2026 (USD Million)
8.6.5. Market size by end-use, 2015 – 2026 (USD Million)
8.6.6. South Africa
8.6.6.1. Market size by application, 2015 – 2026 (USD Million)
8.6.6.2. Market size by product, 2015 - 2026 (USD Million)
8.6.6.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.6.6.4. Market size by end-use, 2015 - 2026 (USD Million)
8.6.7. UAE
8.6.7.1. Market size by application, 2015 – 2026 (USD Million)
8.6.7.2. Market size by product, 2015 - 2026 (USD Million)
8.6.7.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.6.7.4. Market size by end-use, 2015 - 2026 (USD Million)
8.6.8. Saudi Arabia
8.6.8.1. Market size by application, 2015 – 2026 (USD Million)
8.6.8.2. Market size by product, 2015 - 2026 (USD Million)
8.6.8.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.6.8.4. Market size by end-use, 2015 - 2026 (USD Million)
8.6.9. Qatar
8.6.9.1. Market size by application, 2015 – 2026 (USD Million)
8.6.9.2. Market size by product, 2015 - 2026 (USD Million)
8.6.9.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.6.9.4. Market size by end-use, 2015 - 2026 (USD Million)
8.6.10. Kuwait
8.6.10.1. Market size by application, 2015 – 2026 (USD Million)
8.6.10.2. Market size by product, 2015 - 2026 (USD Million)
8.6.10.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.6.10.4. Market size by end-use, 2015 - 2026 (USD Million)
8.6.11. Egypt
8.6.11.1. Market size by application, 2015 – 2026 (USD Million)
8.6.11.2. Market size by product, 2015 - 2026 (USD Million)
8.6.11.3. Market size by matrix type, 2015 - 2026 (USD Million)
8.6.11.4. Market size by end-use, 2015 - 2026 (USD Million)
Chapter 9. Company Profiles
9.1. Competitive dashboard, 2019
9.2. Agarose Bead Technologies (ABT)
9.2.1. Business overview
9.2.2. Financial data
9.2.3. Service landscape
9.2.4. Strategic outlook
9.2.5. SWOT analysis
9.3. Bio-Rad Laboratories, Inc.
9.3.1. Business overview
9.3.2. Financial data
9.3.3. Service landscape
9.3.4. Strategic outlook
9.3.5. SWOT analysis
9.4. Danaher Corporation
9.4.1. Business overview
9.4.2. Financial data
9.4.3. Service landscape
9.4.4. SWOT analysis
9.4.5. Business overview
9.5. EMD Millipore
9.5.1. Business overview
9.5.2. Financial data
9.5.3. Service landscape
9.5.4. Strategic outlook
9.5.5. SWOT analysis
9.6. Expedeon Ltd.
9.6.1. Business overview
9.6.2. Financial data
9.6.3. Service landscape
9.6.4. SWOT analysis
9.7. GE Healthcare
9.7.1. Business overview
9.7.2. Financial data
9.7.3. Service landscape
9.7.4. SWOT analysis
9.8. GenScript Corporation
9.8.1. Business overview
9.8.2. Financial data
9.8.3. Service landscape
9.8.4. Strategic outlook
9.8.5. SWOT analysis
9.9. Novasep
9.9.1. Business overview
9.9.2. Financial data
9.9.3. Service landscape
9.9.4. Strategic outlook
9.9.5. SWOT analysis
9.10. Purolite Life Sciences
9.10.1. Business overview
9.10.2. Financial data
9.10.3. Service landscape
9.10.4. Strategic outlook
9.10.5. SWOT analysis
9.11. Repligen
9.11.1. Business overview
9.11.2. Service landscape
9.11.3. Strategic outlook
9.11.4. SWOT analysis
9.11.5. SWOT analysis
9.12. Sigma-Aldrich Corporation
9.12.1. Business overview
9.12.2. Service landscape
9.12.3. Strategic outlook
9.12.4. SWOT analysis
9.12.5. SWOT analysis
9.13. Takara Bio Inc
9.13.1. Business overview
9.13.2. Service landscape
9.13.3. Strategic outlook
9.13.4. SWOT analysis
9.13.5. SWOT analysis
9.14. Thermo Fisher Scientific
9.14.1. Business overview
9.14.2. Service landscape
9.14.3. Strategic outlook
9.14.4. SWOT analysis
9.14.5. SWOT analysis
9.15. Tosoh Bioscience LLC
9.15.1. Business overview
9.15.2. Service landscape
9.15.3. Strategic outlook
9.15.4. SWOT analysis
9.15.5. SWOT analysis
